Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 15 | 2022 | 91 | 4.190 |
Why?
|
| Action Potentials | 13 | 2023 | 87 | 3.300 |
Why?
|
| Calcium | 7 | 2023 | 364 | 3.070 |
Why?
|
| Heart Atria | 9 | 2023 | 26 | 2.120 |
Why?
|
| Atrial Fibrillation | 4 | 2023 | 120 | 2.090 |
Why?
|
| Calcium Signaling | 6 | 2020 | 116 | 1.760 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2023 | 12 | 1.680 |
Why?
|
| Rabbits | 9 | 2023 | 184 | 1.470 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2022 | 62 | 1.240 |
Why?
|
| Animals | 17 | 2023 | 3510 | 1.150 |
Why?
|
| Chloride Channels | 2 | 2016 | 7 | 1.050 |
Why?
|
| Peptide Hormones | 1 | 2023 | 3 | 0.900 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2023 | 17 | 0.890 |
Why?
|
| Membrane Potentials | 4 | 2022 | 168 | 0.830 |
Why?
|
| Long QT Syndrome | 1 | 2022 | 6 | 0.830 |
Why?
|
| Calcium Channels, L-Type | 4 | 2019 | 52 | 0.820 |
Why?
|
| Heart Failure | 1 | 2023 | 166 | 0.770 |
Why?
|
| Gap Junctions | 4 | 2010 | 12 | 0.750 |
Why?
|
| Excitation Contraction Coupling | 2 | 2021 | 12 | 0.660 |
Why?
|
| Connexins | 4 | 2010 | 4 | 0.590 |
Why?
|
| Sarcoplasmic Reticulum | 4 | 2022 | 159 | 0.560 |
Why?
|
| Heart | 1 | 2017 | 57 | 0.550 |
Why?
|
| Chloride Channel Agonists | 1 | 2016 | 1 | 0.540 |
Why?
|
| Calcium Channels | 1 | 2017 | 106 | 0.540 |
Why?
|
| Patch-Clamp Techniques | 4 | 2017 | 98 | 0.460 |
Why?
|
| Electrocardiography | 1 | 2014 | 101 | 0.460 |
Why?
|
| Cell Membrane Permeability | 2 | 2010 | 54 | 0.430 |
Why?
|
| Myocardial Contraction | 4 | 2021 | 37 | 0.420 |
Why?
|
| Quinolinium Compounds | 1 | 2012 | 1 | 0.410 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2012 | 1 | 0.410 |
Why?
|
| 2-Naphthylamine | 1 | 2012 | 3 | 0.410 |
Why?
|
| Heart Conduction System | 1 | 2012 | 11 | 0.410 |
Why?
|
| Pyridinium Compounds | 1 | 2012 | 6 | 0.410 |
Why?
|
| Body Surface Potential Mapping | 1 | 2012 | 3 | 0.410 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 2022 | 9 | 0.370 |
Why?
|
| Molecular Probes | 1 | 2010 | 2 | 0.370 |
Why?
|
| Cyclic AMP | 1 | 2008 | 29 | 0.300 |
Why?
|
| Ion Channel Gating | 1 | 2008 | 177 | 0.270 |
Why?
|
| Potassium Channels | 3 | 2018 | 37 | 0.250 |
Why?
|
| Cell Communication | 3 | 2010 | 20 | 0.250 |
Why?
|
| Heart Ventricles | 2 | 2016 | 96 | 0.240 |
Why?
|
| Angiotensin II | 1 | 2023 | 4 | 0.230 |
Why?
|
| Calmodulin | 1 | 2023 | 6 | 0.220 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2023 | 20 | 0.220 |
Why?
|
| Male | 7 | 2020 | 13917 | 0.210 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 10 | 0.210 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2022 | 1 | 0.210 |
Why?
|
| Apamin | 1 | 2022 | 3 | 0.210 |
Why?
|
| Sodium | 1 | 2022 | 61 | 0.190 |
Why?
|
| Myocardium | 1 | 2022 | 95 | 0.190 |
Why?
|
| Cells, Cultured | 4 | 2019 | 495 | 0.190 |
Why?
|
| Connexin 26 | 3 | 2010 | 3 | 0.190 |
Why?
|
| Atrial Function | 1 | 2021 | 2 | 0.180 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2020 | 2 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 18 | 0.170 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 11 | 0.170 |
Why?
|
| Muscle Proteins | 1 | 2020 | 32 | 0.170 |
Why?
|
| Heart Rate | 1 | 2020 | 109 | 0.170 |
Why?
|
| Connexin 43 | 2 | 2010 | 6 | 0.170 |
Why?
|
| Uncoupling Agents | 1 | 2019 | 4 | 0.160 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2019 | 7 | 0.160 |
Why?
|
| beta Catenin | 1 | 2020 | 59 | 0.160 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2019 | 15 | 0.160 |
Why?
|
| Humans | 12 | 2021 | 25692 | 0.150 |
Why?
|
| HeLa Cells | 4 | 2010 | 39 | 0.150 |
Why?
|
| Intracellular Space | 1 | 2017 | 5 | 0.140 |
Why?
|
| Kinetics | 1 | 2017 | 179 | 0.140 |
Why?
|
| Models, Biological | 1 | 2017 | 311 | 0.120 |
Why?
|
| Albuterol | 2 | 2005 | 14 | 0.120 |
Why?
|
| Ion Transport | 1 | 2014 | 27 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2014 | 37 | 0.120 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2014 | 21 | 0.120 |
Why?
|
| Anions | 2 | 2010 | 5 | 0.110 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 133 | 0.110 |
Why?
|
| Cations | 2 | 2010 | 15 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 38 | 0.100 |
Why?
|
| Swine | 1 | 2012 | 71 | 0.100 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 2 | 2009 | 10 | 0.100 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 7 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 472 | 0.090 |
Why?
|
| Light | 1 | 2011 | 76 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2010 | 72 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 646 | 0.090 |
Why?
|
| Biological Clocks | 1 | 2009 | 16 | 0.080 |
Why?
|
| Kidney | 1 | 2009 | 155 | 0.080 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2008 | 4 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2008 | 22 | 0.080 |
Why?
|
| Diffusion | 1 | 2008 | 24 | 0.080 |
Why?
|
| Eye Proteins | 1 | 2008 | 4 | 0.080 |
Why?
|
| Electric Conductivity | 1 | 2008 | 66 | 0.070 |
Why?
|
| Cataract | 1 | 2008 | 15 | 0.070 |
Why?
|
| Point Mutation | 1 | 2008 | 25 | 0.070 |
Why?
|
| Permeability | 1 | 2008 | 111 | 0.070 |
Why?
|
| Ion Channels | 1 | 2009 | 206 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 221 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2019 | 49 | 0.060 |
Why?
|
| Dogs | 2 | 2020 | 176 | 0.060 |
Why?
|
| Diuretics, Osmotic | 1 | 2005 | 3 | 0.060 |
Why?
|
| Mannitol | 1 | 2005 | 12 | 0.060 |
Why?
|
| Rats | 2 | 2019 | 649 | 0.060 |
Why?
|
| Time Factors | 2 | 2020 | 1336 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 12 | 0.040 |
Why?
|
| Diastole | 1 | 2020 | 27 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2020 | 3 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 5 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 18 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 35 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 45 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2020 | 49 | 0.040 |
Why?
|
| Insulin | 1 | 2020 | 83 | 0.040 |
Why?
|
| Proton Ionophores | 1 | 2019 | 1 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 217 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2020 | 167 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 182 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2020 | 183 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2020 | 284 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 292 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2020 | 151 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 405 | 0.040 |
Why?
|
| Electrophysiology | 2 | 2008 | 97 | 0.040 |
Why?
|
| Transfection | 2 | 2008 | 112 | 0.040 |
Why?
|
| Mice | 1 | 2020 | 1345 | 0.030 |
Why?
|
| Osmotic Pressure | 2 | 2005 | 5 | 0.030 |
Why?
|
| Female | 2 | 2020 | 14273 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2011 | 1 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 13 | 0.020 |
Why?
|
| Biotin | 1 | 2008 | 7 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 7 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 13 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2008 | 12 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 23 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 50 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 71 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 111 | 0.020 |
Why?
|
| Connexin 30 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2007 | 1 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2007 | 2 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2007 | 5 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 21 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 35 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 262 | 0.020 |
Why?
|
| Osmosis | 1 | 2005 | 4 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 20 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 325 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 7336 | 0.010 |
Why?
|
| Middle Aged | 1 | 2005 | 8403 | 0.010 |
Why?
|
| Aged | 1 | 2005 | 8501 | 0.010 |
Why?
|